Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2015

Mandal Raju K, Agrawal Toshi, Mittal Rama Devi

Abstract excerpt

Chemokines and their receptors acts as mediators of migration of immune cells to the site of inflammation and deregulated inflammatory response is associated with increased risk of cancer. We performed a case-control study to analyze the frequencies of CCL2 (I/D, rs3917887), -2518 (A > G, rs1024611), and CCR2 (G > A, rs1799864) polymorphisms for prostate cancer (PCa) risk. In this hospital-based case-control...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Case-Control Studies
Share to Chemokine CCL2
Share to Epistasis, Genetic
Share to Genetic Association Studies
Share to Prostatic Neoplasms
Share to Receptors, CCR2
Share to Risk

Source

Identifiers

PMID: 25266801
DOI: 10.1007/s13277-014-2646-x

Genes

CCL2
CCR2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.PMID 25266801Read ↗

Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.Semantic proximity Read ↗

Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.Semantic proximity Read ↗

Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.Semantic proximity Read ↗

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility.Semantic proximity Read ↗

Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.Semantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort.Semantic proximity Read ↗

A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.Semantic proximity Read ↗

Significant association of MCP1 rs1024611 and CCR2 rs1799864 polymorphisms with colorectal cancer and liver metastases susceptibility and aggressiveness: A case-control study.Semantic proximity Read ↗

Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.Semantic proximity Read ↗

The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.